Cristiano Rampinelli, MD, Vittoria Vecchi, MD, Massimo Bellomi, MD

Slides:

Advertisements

Similar presentations

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD

Advertisements

Jeffrey Bradley, MD Journal of Thoracic Oncology

Long-Term Surveillance of Ground-Glass Nodules: Evidence from the MILD Trial Silva Mario, MD, Sverzellati Nicola, MD, PhD, Manna Carmelinda, MD, Negrini.

Sequential Immunologic Reactions after Suspension of Nivolumab Treatment in Lung Adenocarcinoma Patient Hiromichi Shirasu, MD, Akira Ono, MD, Toshiaki.

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease Eisaku.

Lungs on Fire Journal of Thoracic Oncology

Computer Vision Tool and Technician as First Reader of Lung Cancer Screening CT Scans Alexander J. Ritchie, MD, Calvin Sanghera, Colin Jacobs, PhD, Wei.

Leptomeningeal and Medullary Response to Second-Line Erlotinib in Lung Adenocarcinoma Mathilde Wagner, MD, Benjamin Besse, MD, Corinne Balleyguier, MD,

Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program Giulia Veronesi, MD, Massimo Bellomi, MD,

Waleed Brinjikji, MD, Jennifer M. Boland Froemming, MD, William P

A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non–Small Cell Lung Cancer Patient Jong Sik Lee, MD, Jae Young Hur, PhD,

Long-Term Follow-up of Small Pulmonary Ground-Glass Nodules Stable for 3 Years: Implications of the Proper Follow-up Period and Risk Factors for Subsequent.

David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F

Radio-Guided Localization and Resection of Small or Ill-Defined Pulmonary Lesions Domenico Galetta, MD, PhD, Massimo Bellomi, MD, Chiara Grana, MD, Lorenzo.

Exogenous Lipoid Pneumonia Mimicking Multifocal Bronchogenic Carcinoma

MET-Mutated NSCLC with Major Response to Crizotinib

Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,

Successful Treatment of Invasive Pulmonary Mucormycosis in an Immunocompromised Patient Oluwatobi Afolayan, BS, Hannah Copeland, MD, Rachel Hargrove,

Rapidly Progressive Diffuse Cystic Lesions as a Radiological Hallmark of Lung Adenocarcinoma Jian Zhang, MD, Yi-Lin Zhao, MD, Ming-Xiang Ye, MD, Gang.

Electronic Updates for JTO Readers

The Moth-Eaten Lung Journal of Thoracic Oncology

An Unusual Presentation of Malignant Pleural Mesothelioma

Successful Crizotinib Retreatment after Crizotinib-Induced Interstitial Lung Disease Satoru Yanagisawa, MD, PhD, Akira Inoue, MD, PhD, Akira Koarai, MD,

Coexistence of the BRAF Mutation and EGFR Exon 20 Insertion in a Patient with Lung Adenocarcinoma Lih-Chyun Chang, MD, Kuan-Yu Chen, MD, PhD, Jin-Yuan.

Oncological Characteristics of Radiological Invasive Adenocarcinoma with Additional Ground-Glass Nodules on Initial Thin-Section Computed Tomography:

A Severe Photosensitivity Dermatitis Caused by Crizotinib

Multiple Pulmonary Chondroid Hamartoma

How Long Should Small Lung Lesions of Ground-Glass Opacity be Followed? Yoshihisa Kobayashi, MD, Takayuki Fukui, MD, Simon Ito, MD, Noriyasu Usami, MD,

Vertebral Collapse Caused by Bone Metastasis

Kiran Devisetty, MD, Joseph K. Salama, MD Journal of Thoracic Oncology

Effective Treatment with Icotinib in Primary Adenoid Cystic Carcinoma of the Lung with Liver Metastasis Zhengbo Song, MD, Wei Wu, MD, Yiping Zhang, MD

Evaluating Cryoablation of Metastatic Lung Tumors in Patients—Safety and Efficacy The ECLIPSE Trial—Interim Analysis at 1 Year Thierry de Baere, MD,

Ritbune Prakobkit, MD, William Churk-Nam Auyeung, MD

Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib Oana Pop, MD, Augustin Pirvu,

Massive Bronchogenic Cyst

Are There Imaging Characteristics Associated with Epidermal Growth Factor Receptor and KRAS Mutations in Patients with Adenocarcinoma of the Lung with.

An unusual case of lateral pulmonary hernia

Elderly Former Smoker with HRAS Mutant Non–Small-Cell Lung Cancer

RET-Rearranged Lung Adenocarcinomas with Lymphangitic Spread, Psammoma Bodies, and Clinical Responses to Cabozantinib Sanjay Mukhopadhyay, MD, Nathan.

Frequency of Lymph Node Metastasis According to the Size of Tumors in Resected Pulmonary Adenocarcinoma with a Size of 30 mm or Smaller Yangki Seok,

Epidermal Growth Factor Receptor Mutation and Pathologic-Radiologic Correlation Between Multiple Lung Nodules with Ground-Glass Opacity Differentiates.

Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS

Identification of a subcentimeter pulmonary adenocarcinoma using intraoperative near- infrared imaging during video-assisted thoracoscopic surgery Jane.

The Role of Surgery in the Management of Primary Thymic Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Kimihiro Shimizu, MD, PhD, Izumi Takeyoshi,

Jennifer L. Dallas, MD, Michael A. Jantz, MD, Judith L

Navigating the lung for hidden treasure

Mirror Mirror on the Wall, Who Is the Fairest of Them All

Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small Cell Lung Cancer Hong Kwan Kim, MD, Yong Soo Choi,

Matthew Reichert, MD, Eric S. Bensadoun, MD

CT Features of Epidermal Growth Factor Receptor–Mutated Adenocarcinoma of the Lung: Comparison with Nonmutated Adenocarcinoma Mizue Hasegawa, MD, PhD,

Jeffrey Bradley, MD Journal of Thoracic Oncology

Multiple Pulmonary Nodules in an Elderly Woman

Nicholas W. Choong, MD, Robert S. Hellman, MD

Beware of the “Bronchocele,” Particularly in Patients with a History or Risk Factors for a Mucinous Carcinoma: A Response to the Article “Resection of.

T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)

Two Generations of Light/Never-Smokers With Advanced Adenocarcinoma of the Lung with Durable Responses to Erlotinib Nathan A. Pennell, MD, PhD, Lihong.

Antiangiogenesis Induced Tumor Cavitation in Lung Cancer

Manoj P. Menon, MD, MPH, Keith D. Eaton, MD, PhD

European Lung Cancer Conference (ELCC) 2016 Organisation

Andreas Rimner, MD, Kenneth E. Rosenzweig, MD

Tetsuzo Tagawa, MD, Miyuki Takasu, MD, Teruyoshi Ishida, MD

Follow-Up of Small (4 mm or Less) Incidentally Detected Nodules by Computed Tomography in Oncology Patients: A Retrospective Review Reginald F. Munden,

Journal of Thoracic Oncology

IASLC 6th Latin American Conference on Lung Cancer

APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28

Long-Term Follow-Up of Ground-Glass Nodules After 5 Years of Stability

David Garfield, MD Journal of Thoracic Oncology

Popcorn in the Lung Journal of Thoracic Oncology

Robert Comis, MD, The Passing of a “Lung Man”

Ana Luque, MD, Edurne Arriola, MD, PhD Journal of Thoracic Oncology

Presentation transcript:

From Reversed Halo Sign to Halo Sign: Unusual Centripetal Growing of a Lung Adenocarcinoma Cristiano Rampinelli, MD, Vittoria Vecchi, MD, Massimo Bellomi, MD Journal of Thoracic Oncology Volume 9, Issue 8, (August 2014) DOI: 10.1097/JTO.0000000000000194 Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 A. Axial computed tomography (CT) scan showed in the right lower lobe a 23 mm ring opacity which surrounds a center of normal lung tissue and ground-glass opacification. (B) Four years later, the CT scan showed a 23 mm ground-glass nodule resulting from the centripetal growth of the ring opacity with a complete ground-glass replacement of the normal lung tissue. (C) At 10 years, the lesion was stable in size (23 mm) but increased in attenuation with the development of a central solid component. Journal of Thoracic Oncology 2014 9, DOI: (10.1097/JTO.0000000000000194) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions